W. Christopher Ehmann

1.9k total citations
43 papers, 1.4k citations indexed

About

W. Christopher Ehmann is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, W. Christopher Ehmann has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 19 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in W. Christopher Ehmann's work include Lymphoma Diagnosis and Treatment (11 papers), Immune Cell Function and Interaction (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). W. Christopher Ehmann is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Immune Cell Function and Interaction (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). W. Christopher Ehmann collaborates with scholars based in United States, China and Japan. W. Christopher Ehmann's co-authors include Witold B. Rybka, David F. Claxton, Hong Zheng, Todd D. Schell, Hamid Al‐Mondhiry, Hui Zeng, Liuluan Zhu, Yaxian Kong, Jianhong Zhang and Melissa R. George and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

W. Christopher Ehmann

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Christopher Ehmann United States	18	762	600	433	318	238	43	1.4k
Jan Maciej Zaucha Poland	20	443 0.6×	448 0.7×	757 1.7×	428 1.3×	374 1.6×	137	1.7k
Deok‐Hwan Yang South Korea	22	727 1.0×	500 0.8×	455 1.1×	688 2.2×	252 1.1×	112	1.6k
Fabienne McClanahan Germany	12	514 0.7×	548 0.9×	218 0.5×	450 1.4×	691 2.9×	35	1.2k
Han Myint United States	14	456 0.6×	453 0.8×	305 0.7×	184 0.6×	245 1.0×	30	1.1k
Anna Dodero Italy	21	898 1.2×	695 1.2×	561 1.3×	948 3.0×	270 1.1×	73	1.7k
MF Martelli Italy	15	376 0.5×	506 0.8×	405 0.9×	544 1.7×	214 0.9×	30	1.2k
Giuseppe Gritti Italy	17	651 0.9×	392 0.7×	138 0.3×	628 2.0×	298 1.3×	59	1.2k
B. Glaß Germany	21	611 0.8×	403 0.7×	345 0.8×	624 2.0×	280 1.2×	55	1.2k
Grete F. Lauritzsen Norway	19	692 0.9×	623 1.0×	134 0.3×	851 2.7×	228 1.0×	34	1.4k
MS Tallman United States	12	629 0.8×	285 0.5×	562 1.3×	350 1.1×	460 1.9×	20	1.5k

Countries citing papers authored by W. Christopher Ehmann

Since Specialization

Citations

This map shows the geographic impact of W. Christopher Ehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Christopher Ehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Christopher Ehmann more than expected).

Fields of papers citing papers by W. Christopher Ehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Christopher Ehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Christopher Ehmann. The network helps show where W. Christopher Ehmann may publish in the future.

Co-authorship network of co-authors of W. Christopher Ehmann

This figure shows the co-authorship network connecting the top 25 collaborators of W. Christopher Ehmann. A scholar is included among the top collaborators of W. Christopher Ehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Christopher Ehmann. W. Christopher Ehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Potiaumpai, Melanie, Kathryn H. Schmitz, Shin Mineishi, et al.. (2023). IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients. BMJ Open. 13(1). e066841–e066841. 5 indexed citations

Zhou, Huarong, Bei Jia, Kentaro Minagawa, et al.. (2023). CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia. Frontiers in Immunology. 14. 1169144–1169144. 5 indexed citations

Jia, Bei, Kevin Rakszawski, David F. Claxton, et al.. (2019). Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia. Cancer Research. 79(7). 1635–1645. 48 indexed citations

Zhu, Liuluan, Yaxian Kong, Jianhong Zhang, et al.. (2017). Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia. Journal of Hematology & Oncology. 10(1). 124–124. 52 indexed citations

Kong, Yaxian, Liuluan Zhu, Todd D. Schell, et al.. (2016). T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients. Clinical Cancer Research. 22(12). 3057–3066. 230 indexed citations

Goy, André, Andres Forero, Nina D. Wagner‐Johnston, et al.. (2016). A phase 2 study of inotuzumab ozogamicin in patients with indolent B‐cell non‐Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy. British Journal of Haematology. 174(4). 571–581. 40 indexed citations

Williams, Michael E., Fangxin Hong, Randy D. Gascoyne, et al.. (2016). Rituximab extended schedule or retreatment trial for low tumour burden non‐follicular indolent B‐cell non‐Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402. British Journal of Haematology. 173(6). 867–875. 30 indexed citations

Pu, Jeffrey J., W. Christopher Ehmann, Jason Liao, et al.. (2016). The Results of a Phase I Study using Velcade (Bortezomib), Cladribine, and Rituximab (VCR) in treating Mantle Cell Lymphoma. Blood. 128(22). 1792–1792. 5 indexed citations

Kahl, Brad S., Fangxin Hong, Michael E. Williams, et al.. (2014). Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402. Journal of Clinical Oncology. 32(28). 3096–3102. 138 indexed citations

10.

Drabick, Joseph J., Giampaolo Talamo, Jeffrey G. Supko, et al.. (2013). A phase II pilot efficacy trial of the combination regimen peg asparaginase/peg liposomal doxorubicin/dexamethasone (ODD) in patients with refractory lymphoid malignancies (NCT00837200).. Journal of Clinical Oncology. 31(15_suppl). e19502–e19502. 1 indexed citations

11.

Zhu, Junjia, W. Christopher Ehmann, Elliot Epner, et al.. (2012). G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation. Bone Marrow Transplantation. 48(3). 357–362. 18 indexed citations

12.

Talamo, Giampaolo, et al.. (2012). Perceived Levels of Pain Associated with Bone Marrow Aspirates and Biopsies. PubMed. 10(4). 166–170. 9 indexed citations

13.

Bayerl, Michael G., et al.. (2009). Multiple cutaneous monoclonal B‐cell proliferations as harbingers of systemic angioimmunoblastic T‐cell lymphoma. Journal of Cutaneous Pathology. 37(7). 777–786. 18 indexed citations

14.

Bayerl, Michael G., et al.. (2004). Lacunar and Reed-Sternberg-Like Cells in Follicular Lymphomas Are Clonally Related to the Centrocytic and Centroblastic Cells as Demonstrated by Laser Capture Microdissection. American Journal of Clinical Pathology. 122(6). 858–864. 1 indexed citations

15.

Clarke, Loren E., Michael G. Bayerl, W. Christopher Ehmann, & Klaus F. Helm. (2003). Cutaneous B‐cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy. Journal of Cutaneous Pathology. 30(7). 459–462. 17 indexed citations

16.

Ehmann, W. Christopher, C. S. Rabkin, M. Elaine Eyster, & James J. Goedert. (1997). Thrombocytopenia in HIV-infected and uninfected hemophiliacs. American Journal of Hematology. 54(4). 296–300. 11 indexed citations

17.

Al‐Mondhiry, Hamid & W. Christopher Ehmann. (1994). Congenital afibrinogenemia. American Journal of Hematology. 46(4). 343–347. 57 indexed citations

18.

Ehmann, W. Christopher & Hamid Al‐Mondhiry. (1994). Congenital afibrinogenemia and splenic rupture. The American Journal of Medicine. 96(1). 92–94. 23 indexed citations

19.

Ehmann, W. Christopher. (1992). Cephalosporin‐induced hemolysis: A case report and review of the literature. American Journal of Hematology. 40(2). 121–125. 31 indexed citations

20.

Miele, Monica, E.S. Vesell, W. Christopher Ehmann, et al.. (1992). Hormonal and immunological regulation of 2′,5′-oligoadenylate synthetase activity in human peripheral blood mononuclear cells. Clinical Immunology and Immunopathology. 65(2). 183–192. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact